
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
Pharmamel Spin-Off biotech R&D&I biotech spin-off from the University of Granada, which holds the technology license from the Andalusian Health Service and the University of Granada for an intravenous melatonin injectable to treat sepsis (the leading cause of hospital death in the world) After conducting two Phase II clinical trials and successfully demonstrating the safety and efficacy of the drug, the company has the perfect drug candidate
Investigación y desarrollo,salud,melatonina,i+d+i,and enfermedades inflamatorias
Pharmamel drug discovery operates in the Pharmaceutical manufacturing industry.
Pharmamel drug discovery's revenue is 11m - 100m
Pharmamel drug discovery has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.